+91-8668442535

Mobile Cardiac Telemetry Systems Market By Product Type (Lead Based, Patch Based), By End User Segment (Hospitals, Clinics, Ambulatory Surgical Centers) - Growth, Future Prospects, And Competitive Analysis, 2019 - 2027

"Mobile cardiac telemetry systems market to exhibit dynamic growth during the forecast period."

The global mobile cardiac telemetry systems market is mounting competently, growing at a healthier CAGR of 9.1%. Mobile cardiac telemetry systems are used for real-time remote monitoring and transmitting cardiac measures to doctors or physicians. These are mainly applied for disease indications such as cardiac arrhythmia, heart-related conditions, atrial fibrillation, etc. Worldwide, growing incidences and prevalence of cardiac disorders, heart failure among the adult population (mainly above 55 years), and increasing need for advanced and quick real-time monitoring of patients along with enhanced patient safety will drive the overall market growth.

Market Synopsis

"Lead-based segment expected to capture a larger market share by 2027."

Advancements in the lead-based and patch-based, along with the development in the field of real-time data monitoring, will improve the overall growth globally. Increased focus on cardio activities and responses of mobile devices will improve the general state of the cardiovascular diagnostics industry. The lead-based segment represents around 65% of the market share globally. Improved diagnostic yield of mobile cardiac devices is expected to generate great demand from patients. As a result, advanced patch-based telemetry systems are expected to register a CAGR of more than 9.0% in revenue from 2020 to 2024. 

Furthermore, the increasing demand in the home care settings is gaining traction slowly owing to speedy expansion in the ageing population. The growing incidence of cardiovascular disorders is expected to generate higher growth opportunities for mobile cardiac system manufacturers in the near future. The global market generally suffers from a deficiency of product diversity and concentrated price battles. Nevertheless, manufacturers can gain traction from an improved focus on commercializing their brands globally and retaining cost-containment processes.

"Hospitals generated maximum revenue share in 2018."

The hospital segment generated the maximum market share in the global market. The utilization of lead-based technology is high. Increased hospital admissions for cardiovascular diseases, heart conditions, and other disorders will boost the market growth. As of 2016, around 28 Mn individuals in the USA were diagnosed with heart disease. Russia has the highest prevalence of heart-related disease, with more than 1,750 heart disease-related deaths per 100,000 individuals. In 2016, more than 17.5 Mn people died from cardiovascular-related diseases, representing around 30% of all worldwide deaths. 

Advancements in bioengineered technology, FDA approval of new devices, an increasing population with cardiac issues, and improved outcomes with real-time monitoring will drive the overall market growth for the mobile cardiac telemetry systems market. In addition, increasing awareness and utilization of lead-based systems in hospitals and ASCs will show significant growth in the near future.

"Increasing adult population, the launch of new mobile devices and the presence of top manufacturers hold the U.S. market in a dominant position."

In 2018, the North American region accounted for the maximum market share globally due to an upsurge in admissions for cardiac disorders and increasing rates of heart failure, atherosclerosis, angina pectoris, and others. In addition, approval of new mobile devices, mainly in the diagnostics segment that includes real-time monitoring of a patient ECG, will have unprecedented levels of relevancy. 

Presently, overall patient cardiac monitoring (on & off site) is rowing efficiently in the developed nations; the prevalence and burden of chronic diseases will further spur revenue growth. However, real-time accuracy, patient data security, less awareness and usage among the physicians in the emerging regions, high cost, and unstructured product penetration are a few major factors restraining the market growth on a global scale.

"Increased research and development with strong product pipelines in the developed regions"

Major players operating in the U.S. mobile cardiac telemetry systems market are Medtronic, Philips, Medicomp Inc., Siemens, and others, generating maximum revenue share. Players are developing with advanced monitoring expertise along with integrated solutions. Partnerships with small-scale service providers, acquisitions, and improved R&D on top medical technology will invent the development of the mobile cardiac telemetry systems market in emerging nations shortly. 

Key Industry Developments 

  • In March 2019, VirtuOx (home respiratory diagnostic provider) launched a new service named CardioCHECK to diagnose cardiac arrhythmias. 
  • Biotricity Inc. (a medical diagnostic and healthcare technology company) received its 510(k) clearance for its Bioflux device with the U.S. FDA.

List of Companies Covered:

  • Medtronic Plc
  • Medicomp Inc.
  • BioTelemetry Inc.
  • ZOLL Medical Corporation
  • Welch Allyn
  • ScottCare Corporation Solution
  • Siemens Healthcare Pvt. Ltd
  • Biotricity Inc.
  • Preventice Solutions
  • Telerhythmics LLC.
  • Applied Cardiac Systems Inc.
  • Philips Benelux 

Historical & Forecast Period

This study report represents analysis for each segment from 2017 to 2027, considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.

Segmentation Product Type (2017–2027; US$ Mn)

  • Lead Based
  • Patch Based

 End User Segment (2017–2027; US$ Mn)

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

 Geography Segment (2017–2027; US$ Mn)

  • North America (U.S. and Rest of North America)
  • Europe (U.K., Germany, France, and Rest of Europe)
  • Asia Pacific (Japan, China, India, and Rest of Asia Pacific)
  • Rest of World (Middle East & Africa (MEA), Latin America)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities better to understand the overall mobile cardiac telemetry systems market. In addition, the global report also represents the competitive landscape based on market initiatives and strategies, product portfolio, and business strengths. 

Frequently Asked Questions

The market for Mobile Cardiac Telemetry Systems is expected to reach US XX Bn in 2028.

The Mobile Cardiac Telemetry Systems market is expected to see significant CAGR growth over the coming years, at 9.1%.

The report is forcasted from 2019-2027.

The base year of this report is 2021.

Medtronic Plc, Medicomp Inc., BioTelemetry Inc., ZOLL Medical Corporation, Welch Allyn, ScottCare Corporation Solution, Siemens Healthcare Pvt. Ltd, Biotricity Inc., Preventice Solutions are some of the major players in the global market.

Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Godaddy
Published Date:  Jan 2020
Category:  Medical Devices
Report ID:   60147
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support